| Ytd | -19.55% | |
| 1y | 16.83% |
| Open | 39.25 | Prev Close | 40.70 | Low | 37.70 | High | 43.00 | Mkt Cap | 1.47B |
| Vol | 1.93M | Avg Vol | 796.82K | EPS | 0.09 | P/E | 438.00 | Forward P/E | 15.21 |
| Beta | 0.25 | Short Ratio | 9.32 | Inst. Own | 58.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 40.14 | 200-d Avg | 41.11 | 1yr Est | 67.75 |
Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript
Harrow NASDAQ: HROW reported second-quarter revenue of $70.7 million, up 11% from a year earlier and
U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26
Harrow (HROW) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate
NASHVILLE, Tenn., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 11, 2026 Comp
A real-world PMS study based on a large population demonstrates comparable safety profile of SB11 (B
NASHVILLE, Tenn., July 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph
Expands Harrow's Growing Retina Portfolio with an Interchangeable Ranibizumab Biosimilar Expands Har
INCHEON, Korea--(BUSINESS WIRE)-- #Byooviz--Samsung Bioepis Co., Ltd. today announced the relaunch o
Harrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an F
Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic e
NASHVILLE, Tenn., June 10, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of oph
NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of opht
MONSEY, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating
Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript
Harrow NASDAQ: HROW executives said the company's first-quarter results were weighed down by a discr
U.S. stock futures lower, Nasdaq down 200 points. AST SpaceMobile shares dip 11% after reporting wor
Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui
Harrow (HROW) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate
First Quarter 2026 and Selected Highlights: VEVYE® delivered record new and total prescription perf
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings
NASHVILLE, Tenn., April 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of op
State of Alaska Department of Revenue lifted its holdings in shares of Harrow, Inc. (NASDAQ: HROW) b
Harrow has delivered a decade-long 40% CAGR in revenue, with robust operating leverage and EBITDA ma
MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue o
Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported bet
U.S. stock futures lower, Dow futures down 1%. Yatsen Holding shares fall 10.1%, while other stocks
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly